Legal & General Group’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Legal & General Group’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-153,183	Closed	-$388K	–	3405
2023 Q4	$388K	Buy	153,183 +9,371	+7%	+$21.8K	﹤0.01%	2547
2023 Q3	$344K	Buy	143,812 +20,905	+17%	+$46.3K	﹤0.01%	2578
2023 Q2	$284K	Buy	122,907 +67,185	+121%	+$190K	﹤0.01%	2649
2023 Q1	$142K	Buy	55,722 +4,126	+8%	+$11.8K	﹤0.01%	2698
2022 Q4	$130K	Buy	51,596 +2,983	+6%	+$8.32K	﹤0.01%	2754
2022 Q3	$141K	Buy	48,613 +1,359	+3%	+$5.72K	﹤0.01%	2729
2022 Q2	$213K	Buy	+47,254	New	+$281K	﹤0.01%	2607

Legal & General Group's SLGC Position: Q1 2024 in Review

Legal & General Group sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 153,183 shares — an estimated $388K sold.

Legal & General Group first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $388K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Legal & General Group reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Legal & General Group sold 153,183 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $388K.
Legal & General Group first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Legal & General Group's SomaLogic, Inc. Class A Common Stock position peaked at $388K in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Legal & General Group's 13F filing for Q1 2024, filed 14 May 2024.